The BRIC diabetes care devices market is estimated to grow at a CAGR of 6.3% from 2015 to 2020, to reach USD 2.3 Billion by 2020 from USD 1.7 Billion in 2015.

The BRIC diabetes care devices market has witnessed major growth in the past few years, and is largely driven by the increasing number of diabetic patients across BRIC countries, growing research on diabetes, and increasing international research collaborations.

Growth Factors:
Factors such as increasing number of diabetic patients across BRIC countries, growing research on diabetes, and increasing international research collaborations are driving the growth of the this market. Rising obese population and lifestyle changes (driving the prevalence of diabetes among the urban population) are further contributing to the growth of this market.

Download PDF Brochure: https://tinyurl.com/yccxcexd

China accounted for the largest share of the BRIC diabetes care devices market; it accounted for a market share of 55.5% in 2014.

The Indian market, on the other hand, is expected to witness the highest CAGR, mainly due to the growing diabetic population, rapid urbanization and industrialization, and growing research on diabetes and its management.

Market Trends:
1. Growing Diabetes Care Market in India
2. Shift Towards Continuous Glucose Monitors
3. Development of Noninvasive Glucometers
4. Technological Advancements

Key Players:
Becton, Dickinson and Company (U.S.), Roche Diagnostics Ltd. (Switzerland), Johnson and Johnson (U.S.), Bayer AG (Germany), Abbott Laboratories (U.S.), Acon Laboratories, Inc. (U.S.), Ypsomed AG (Switzerland), Novo Nordisk A/S (Denmark), Medtronic plc (Ireland), ARKRAY Inc. (Japan), Terumo Corporation (Japan), Dexcom, Inc. (U.S.), and Sanofi (France).
To Know More About BRIC Market Analysis, Download FREE Sample Report Pages: https://tinyurl.com/yb6u5ne6